China Botanic Pharmaceutical (CBP) Reports Q3 Earnings of $0.07; Affirms Outlook

China Botanic Pharmaceutical (NYSE: CBP) reported Q3 EPS of $0.07, versus $0.04 reported last year. Revenue for the quarter came in at $12.4 million, versus $9.3 million reported last year.

Affirms outlook.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Celcuity (CELC) Reiterates at Market Outperform by Citizens Ahead of Upcoming Launch
• JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight